Nociceptin/Orphanin FQ Receptor - How is Nociceptin/Orphanin FQ Receptor abbreviated?
NOPR (redirected from Nociceptin/Orphanin FQ Receptor)
|NOPR||Notice of Proposed Rulemaking|
|NOPR||Nociceptin/Orphanin FQ Receptor (opioids)|
|NOPR||Noprint (assembly language ASM51 assembler control)|
|NOPR||Notice of Proposed Regulation (US FERC)|
|NOPR||National Oncologic PET (Positron Emission Tomography) Registry (Philadelphia, PA)|
References in periodicals archive
The nociceptin/orphanin FQ receptor
: a target with broad therapeutic potential.
De Nardo et al., "Activation of the nociceptin/orphanin FQ receptor
reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux," British Journal of Pharmacology, vol.
The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo.
Matteis et al., "Nociceptin/orphanin FQ receptor
activation decreases the airway hyperresponsiveness induced by allergen in sensitized mice," American Journal of Physiology--Lung Cellular and Molecular Physiology, vol.
Calo' et al., "Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor
," Naunyn-Schmiedeberg's Archives of Pharmacology, vol.